Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model
Paul M. Schroder, Robin Schmitz, Zachary W. Fitch, Brian Ezekian, Janghoon Yoon, Ashley Y. Choi, Miriam Manook, Andrew S. Barbas, Frank V. Leopardi, Mingqing Song, Alton B. Farris, Bradley H. Collins, Jean Kwun, Stuart J. Knechtle
Topics & Concepts
CarfilzomibBelataceptMedicineDesensitization (medicine)BasiliximabImmunosuppressionImmunologyAnti-thymocyte globulinCalcineurinTransplantationTacrolimusInternal medicineKidney transplantationPharmacologyProteasome inhibitorReceptorMultiple myelomaKidney transplantT-cell and B-cell ImmunologyRenal Transplantation Outcomes and TreatmentsImmune Cell Function and Interaction